Possible side effects of IMCIVREE


Actor portrayals
IMCIVREE has a well-established safety and tolerability profile
The most common side effects of IMCIVREE include:
- Darkening of the skin (hyperpigmentation)
- Injection site reactions
- Nausea
- Headache
- Diarrhea
- Stomach pain
- Vomiting
- Depression
- Erection that happens without
any sexual activity in males
In the acquired HO clinical trial for IMCIVREE, nausea and vomiting were most often reported within the first month of treatment and then declined.
These are not all the possible side effects of IMCIVREE. Call your doctor for medical advice about side effects. Please see additional Important Safety Information below.
The safety of IMCIVREE has been evaluated in more than 700 people over 10+ years through clinical trials and real-world experience across multiple approved uses.
Select Monitoring Considerations
If you have adrenal insufficiency and/or diabetes insipidus (also called arginine vasopressin deficiency), talk to your healthcare provider.
Adrenal Insufficiency
Your healthcare provider should evaluate your adrenal function before starting IMCIVREE. You or your caregiver should call your healthcare provider if you have changes in feeling tired or exhausted (fatigue), lack of energy (lethargy), mental status, or dizziness, or fever, or signs of infection during treatment with IMCIVREE. Your healthcare provider should monitor and adjust any medicines that may be affected during treatment.
Diabetes Insipidus (also called arginine vasopressin deficiency)
You or your caregiver should watch for signs of dehydration. You or your caregiver should contact your healthcare provider if you have changes in fluid intake or urine output, confusion, lethargy, or nausea and vomiting during treatment with IMCIVREE. Your healthcare provider should closely monitor sodium levels in your blood and adjust your other medicines if needed.
A general darkening of the skin (hyperpigmentation) is expected because of how IMCIVREE works
Examples of hyperpigmentation
- Darkening of the skin and/or hair is expected, as IMCIVREE may lead to increased production of melanin (which gives color to your skin and hair)
- The degree of skin darkening can vary from person to person and can sometimes include darkening of existing skin growths (such as moles); the degree of darkening may depend on how much natural melanin a person has
- In the clinical trials, hyperpigmentation increased over the first several weeks of IMCIVREE use and generally leveled off in the initial months of treatment
- Darkening of the skin went away after people stopped using IMCIVREE
- If hyperpigmentation is a concern, talk to your doctor and they will assess your response to treatment and work with you to create a plan to check for skin changes
You should have a full-body skin exam before starting and during treatment with IMCIVREE to check for skin changes.
Please review all the possible side effects of IMCIVREE included in the Patient Information and talk to your doctor about any questions you may have.
Rhythm InTune is committed to helping you
Your Rhythm InTune Patient Education Manager (PEM)* can provide one-on-one support throughout your treatment experience and share educational resources with you along the way.
*Patient Education Managers are employees of Rhythm Pharmaceuticals and do not provide medical care or advice. We encourage you to always speak to your healthcare providers regarding your medical care.
Talk to your doctor about IMCIVREE with help from our discussion guide.
Learn more about how to take IMCIVREE.




